Angelag Fleischmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Catherine C. Coombs, MD, discusses future directions for BTK inhibitors in chronic lymphocytic leukemia and combination therapies in myelofibrosis.

United statesCatherinec coombsAngelag fleischmannNaveen pemmarajuJoshuaf zeidnerInternational consensus classificationSchool of medicineDivision of hematologyDepartment of medicineWorld health organizationUniversity of california irvineOnclive institutional perspectivesCalifornia irvineNew england journalChapel hillInternational consensus